Laobaixing Pharmacy - Asset Resilience Ratio

Latest as of September 2024: 0.01%

Laobaixing Pharmacy (603883) has an Asset Resilience Ratio of 0.01% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Laobaixing Pharmacy total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.50 Million
≈ $219.50K USD Cash + Short-term Investments

Total Assets

CN¥21.21 Billion
≈ $3.10 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2023)

This chart shows how Laobaixing Pharmacy's Asset Resilience Ratio has changed over time. See shareholders equity of Laobaixing Pharmacy for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Laobaixing Pharmacy's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 603883 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.50 Million 0.01%
Total Liquid Assets CN¥1.50 Million 0.01%

Asset Resilience Insights

  • Limited Liquidity: Laobaixing Pharmacy maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Laobaixing Pharmacy Industry Peers by Asset Resilience Ratio

Compare Laobaixing Pharmacy's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Corporativo Fragua S.A.B. de C.V
MX:FRAGUAB
Pharmaceutical Retailers 0.43%
High Tide Inc
V:HITI
Pharmaceutical Retailers 0.03%
Raia Drogasil S.A
SA:RADL3
Pharmaceutical Retailers 0.08%
Empreendimentos Pague Menos S.A
SA:PGMN3
Pharmaceutical Retailers 0.88%
d1000 Varejo Farma Participações S.A
SA:DMVF3
Pharmaceutical Retailers 0.59%
Yifeng Pharmacy
SHG:603939
Pharmaceutical Retailers 19.16%
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
Pharmaceutical Retailers 0.94%
Yunnan Hongxiang Yixintang
SHE:002727
Pharmaceutical Retailers 4.83%

Annual Asset Resilience Ratio for Laobaixing Pharmacy (2015–2023)

The table below shows the annual Asset Resilience Ratio data for Laobaixing Pharmacy.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.01% CN¥1.50 Million
≈ $219.50K
CN¥21.23 Billion
≈ $3.11 Billion
-0.01pp
2022-12-31 0.01% CN¥3.00 Million
≈ $438.99K
CN¥21.40 Billion
≈ $3.13 Billion
0.00pp
2021-12-31 0.02% CN¥3.00 Million
≈ $438.99K
CN¥16.96 Billion
≈ $2.48 Billion
-0.21pp
2020-12-31 0.23% CN¥25.90 Million
≈ $3.79 Million
CN¥11.28 Billion
≈ $1.65 Billion
+0.10pp
2019-12-31 0.13% CN¥13.12 Million
≈ $1.92 Million
CN¥9.92 Billion
≈ $1.45 Billion
-0.08pp
2018-12-31 0.21% CN¥17.73 Million
≈ $2.60 Million
CN¥8.48 Billion
≈ $1.24 Billion
+0.07pp
2017-12-31 0.14% CN¥9.32 Million
≈ $1.36 Million
CN¥6.70 Billion
≈ $980.26 Million
+0.07pp
2016-12-31 0.07% CN¥3.49 Million
≈ $510.25K
CN¥4.91 Billion
≈ $718.44 Million
-0.02pp
2015-12-31 0.09% CN¥3.58 Million
≈ $524.54K
CN¥3.80 Billion
≈ $556.14 Million
--
pp = percentage points

About Laobaixing Pharmacy

SHG:603883 China Pharmaceutical Retailers
Market Cap
$1.55 Billion
CN¥10.62 Billion CNY
Market Cap Rank
#7239 Global
#1714 in China
Share Price
CN¥14.00
Change (1 day)
-0.78%
52-Week Range
CN¥12.89 - CN¥22.52
All Time High
CN¥331.82
About

LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more